Tag - cancer

 
 

CANCER

Japan Times
COMMENTARY / World
Oct 31, 2022
Better cancer screenings are coming. Can we afford them?
Regular cancer tests are an important tool for catching tumors early, but the financial incentives of hospitals and patients aren't always aligned.
Japan Times
COMMENTARY / World
Oct 12, 2022
Don’t cancel your colonoscopy just yet
Data from a large trial on colonoscopies appears to cast doubt over the benefits of the colon cancer screen. But it's a lot more complicated.
Japan Times
WORLD
Oct 10, 2022
Screening procedure fails to prevent colon cancer deaths in large study
While people who underwent the exam were 18% less likely to develop colon cancer, the overall death rate among screened and unscreened people were the same at about 0.3%.
Japan Times
WORLD
Sep 30, 2022
The last days of an outback town where every breath can be toxic
Once a symbol of economic prosperity, Wittenoom is now a ghost town, polluted by decades of asbestos mining.
Japan Times
JAPAN
Sep 5, 2022
Bone marrow donor registrations in Japan hit by pandemic
The pace of increase in the number of donor registrations slowed significantly to 1,919 in 2020, before moderately recovering to 9,478 in 2021.
Japan Times
BUSINESS
Aug 12, 2022
Johnson & Johnson to end global sales of talc-based baby powder
The company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen.
Japan Times
JAPAN
Jul 20, 2022
No direct health effects seen from Fukushima nuclear crisis, ex-U.N. panel chair says
The conclusion of the U.N. Scientific Committee on the Effects of Atomic Radiation is 'unlikely to change significantly in the foreseeable future,' Gillian Hirth said.
Japan Times
BUSINESS / Companies
Jul 15, 2022
SoftBank-backed cancer detection startup may go public as soon as 2023
AI Medical Service Inc. develops software to scan endoscopy images and identify potential cancers.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
WORLD / FOCUS
Feb 5, 2022
Inside Johnson & Johnson’s secret plan to cap litigation payouts to cancer victims
If J&J succeeds, some experts argue, it could provide a blueprint for corporate America on how to circumvent jury trials involving allegations of defective products or misconduct.
Japan Times
JAPAN / Science & Health / Regional voices: Chubu
Nov 8, 2021
Parents and children in Japan unaware HPV vaccines are available for free
In Japan, about 11,000 women mainly in their 20s through 40s suffer from cervical cancer every year, of which about 2,800 die from the disease.
Japan Times
BUSINESS / FOCUS
Jun 4, 2021
Chinese drugmakers take aim at lucrative U.S. anti-cancer market
In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?